fanta.bio Sample: CNhs11857
18199 enriched TFs, sorted by log₁₀ q-value (most significant first).
| TF | Cell Type | Active overlap | Inactive overlap | log₁₀ p-value | log₁₀ q-value | Fold-enrichment |
|---|---|---|---|---|---|---|
| TP53 SRX1547996 | Dermal fibroblast Epidermis | 1094 / 11891 (9.2%) | 303 / 118910 (0.3%) | −324.0 | −324.0 | 36.11 |
| HIF1A SRX11007095 | HK-2 Kidney | 2121 / 11891 (17.8%) | 698 / 118910 (0.6%) | −324.0 | −324.0 | 30.39 |
| TP53 SRX1547998 | Dermal fibroblast Epidermis | 1556 / 11891 (13.1%) | 566 / 118910 (0.5%) | −324.0 | −324.0 | 27.49 |
| TP53 SRX19538279 | Osteoblasts Bone | 495 / 11891 (4.2%) | 199 / 118910 (0.2%) | −324.0 | −324.0 | 24.87 |
| DVL1 SRX22740968 | MDA-MB-231 Breast | 1423 / 11891 (12.0%) | 605 / 118910 (0.5%) | −324.0 | −324.0 | 23.52 |
| DVL1 SRX22740969 | MDA-MB-231 Breast | 1980 / 11891 (16.7%) | 895 / 118910 (0.8%) | −324.0 | −324.0 | 22.12 |
| DVL1 SRX22740970 | MDA-MB-231 Breast | 1917 / 11891 (16.1%) | 912 / 118910 (0.8%) | −324.0 | −324.0 | 21.02 |
| SCML2 SRX644728 | 293 Kidney | 1099 / 11891 (9.2%) | 600 / 118910 (0.5%) | −324.0 | −324.0 | 18.32 |
| MYH11 SRX265221 | ME-1 Blood | 742 / 11891 (6.2%) | 455 / 118910 (0.4%) | −324.0 | −324.0 | 16.31 |
| FOXP1 SRX736067 | LNCAP Prostate | 1465 / 11891 (12.3%) | 922 / 118910 (0.8%) | −324.0 | −324.0 | 15.89 |
| BRD4 SRX9419935 | BT-474 Breast | 2877 / 11891 (24.2%) | 2151 / 118910 (1.8%) | −324.0 | −324.0 | 13.38 |
| BRD4 SRX9419937 | BT-474 Breast | 2876 / 11891 (24.2%) | 2153 / 118910 (1.8%) | −324.0 | −324.0 | 13.36 |
| MED1 SRX9419944 | BT-474 Breast | 2801 / 11891 (23.6%) | 2105 / 118910 (1.8%) | −324.0 | −324.0 | 13.31 |
| MED1 SRX9419945 | BT-474 Breast | 2848 / 11891 (24.0%) | 2147 / 118910 (1.8%) | −324.0 | −324.0 | 13.27 |
| BRD4 SRX9419936 | BT-474 Breast | 2887 / 11891 (24.3%) | 2214 / 118910 (1.9%) | −324.0 | −324.0 | 13.04 |
| MED1 SRX9419946 | BT-474 Breast | 2911 / 11891 (24.5%) | 2239 / 118910 (1.9%) | −324.0 | −324.0 | 13.00 |
| BRD4 SRX9419938 | BT-474 Breast | 2878 / 11891 (24.2%) | 2245 / 118910 (1.9%) | −324.0 | −324.0 | 12.82 |
| MED1 SRX9419947 | BT-474 Breast | 2801 / 11891 (23.6%) | 2222 / 118910 (1.9%) | −324.0 | −324.0 | 12.61 |
| EZH2 SRX2146136 | LNCAP Prostate | 6028 / 11891 (50.7%) | 6025 / 118910 (5.1%) | −324.0 | −324.0 | 10.01 |
| BRD4 SRX736201 | 90-8TL Neural | 4609 / 11891 (38.8%) | 4954 / 118910 (4.2%) | −324.0 | −324.0 | 9.30 |
| Epitope tags SRX20419389 | Keratinocytes Epidermis | 1440 / 11891 (12.1%) | 1951 / 118910 (1.6%) | −324.0 | −324.0 | 7.38 |
| HIF1A SRX20663235 | HK-2 Kidney | 460 / 11891 (3.9%) | 188 / 118910 (0.2%) | −322.1 | −318.9 | 24.47 |
| TP53 SRX19538268 | U2OS Bone | 400 / 11891 (3.4%) | 124 / 118910 (0.1%) | −301.1 | −297.9 | 32.26 |
| PBX4 SRX2731658 | PC-3 Prostate | 539 / 11891 (4.5%) | 18641 / 118910 (15.7%) | −300.4 | −297.3 | 0.29 |
| TP53 SRX19538276 | U2OS Bone | 404 / 11891 (3.4%) | 133 / 118910 (0.1%) | −299.6 | −296.5 | 30.38 |
| TP53 SRX19538274 | U2OS Bone | 400 / 11891 (3.4%) | 127 / 118910 (0.1%) | −299.3 | −296.2 | 31.50 |
| TP53 SRX19538280 | Osteoblasts Bone | 390 / 11891 (3.3%) | 148 / 118910 (0.1%) | −278.6 | −275.5 | 26.35 |
| TP53 SRX19538275 | U2OS Bone | 371 / 11891 (3.1%) | 119 / 118910 (0.1%) | −276.8 | −273.8 | 31.18 |
| TP53 SRX19538267 | U2OS Bone | 357 / 11891 (3.0%) | 110 / 118910 (0.1%) | −269.0 | −265.9 | 32.45 |
| TP53 SRX19538273 | U2OS Bone | 350 / 11891 (2.9%) | 111 / 118910 (0.1%) | −261.8 | −258.8 | 31.53 |
| HMGB1 SRX2765964 | HUVEC Cardiovascular | 1242 / 11891 (10.4%) | 3612 / 118910 (3.0%) | −259.5 | −256.4 | 3.44 |
| YAP1 SRX757325 | H2052 Lung | 366 / 11891 (3.1%) | 14523 / 118910 (12.2%) | −259.1 | −256.1 | 0.25 |
| TP53 SRX19538281 | Osteoblasts Bone | 402 / 11891 (3.4%) | 216 / 118910 (0.2%) | −257.8 | −254.8 | 18.61 |
| CHD1 SRX2268291 | Mesenchymal stem cells Others | 1042 / 11891 (8.8%) | 2621 / 118910 (2.2%) | −256.0 | −253.0 | 3.98 |
| IRF3 SRX11453858 | Hep G2 Liver | 302 / 11891 (2.5%) | 58 / 118910 (0.0%) | −250.6 | −247.6 | 52.07 |
| TP53 SRX19538269 | U2OS Bone | 431 / 11891 (3.6%) | 306 / 118910 (0.3%) | −248.5 | −245.5 | 14.09 |
| CHD1 SRX2268289 | Mesenchymal stem cells Others | 553 / 11891 (4.7%) | 669 / 118910 (0.6%) | −243.7 | −240.7 | 8.27 |
| CTNNB1 SRX13991431 | MCF 10A Breast | 364 / 11891 (3.1%) | 177 / 118910 (0.1%) | −241.3 | −238.4 | 20.57 |
| FOS SRX150477 | MCF 10A Breast | 360 / 11891 (3.0%) | 13805 / 118910 (11.6%) | −238.0 | −235.0 | 0.26 |
| FOS SRX150478 | MCF 10A Breast | 384 / 11891 (3.2%) | 14179 / 118910 (11.9%) | −236.7 | −233.7 | 0.27 |
| TP53 SRX19538270 | U2OS Bone | 413 / 11891 (3.5%) | 302 / 118910 (0.3%) | −235.1 | −232.2 | 13.68 |
| YAP1 SRX757326 | H2052 Lung | 317 / 11891 (2.7%) | 12958 / 118910 (10.9%) | −234.9 | −232.0 | 0.24 |
| FOXA2 SRX4677296 | CFPAC-1 Pancreas | 352 / 11891 (3.0%) | 13087 / 118910 (11.0%) | −218.4 | −215.5 | 0.27 |
| TP53 SRX19538282 | Osteoblasts Bone | 348 / 11891 (2.9%) | 215 / 118910 (0.2%) | −211.9 | −209.1 | 16.19 |
| IRF3 SRX11453861 | Hep G2 Liver | 260 / 11891 (2.2%) | 57 / 118910 (0.0%) | −210.6 | −207.7 | 45.61 |
| CHD1 SRX2268290 | Mesenchymal stem cells Others | 504 / 11891 (4.2%) | 676 / 118910 (0.6%) | −207.9 | −205.0 | 7.46 |
| FOXA1 SRX4815198 | MCF-7 Breast | 627 / 11891 (5.3%) | 17121 / 118910 (14.4%) | −207.2 | −204.3 | 0.37 |
| TP53 SRX19538271 | U2OS Bone | 549 / 11891 (4.6%) | 866 / 118910 (0.7%) | −202.4 | −199.5 | 6.34 |
| FOS SRX4192880 | MCF 10A Breast | 274 / 11891 (2.3%) | 11218 / 118910 (9.4%) | −201.6 | −198.7 | 0.24 |
| KAT6A SRX20971022 | Fibroblasts Others | 252 / 11891 (2.1%) | 60 / 118910 (0.1%) | −200.8 | −198.0 | 42.00 |
| DNMT3B SRX3275107 | iPS cells Pluripotent stem cell | 500 / 11891 (4.2%) | 700 / 118910 (0.6%) | −200.4 | −197.6 | 7.14 |
| AGO2 SRX4708039 | Hep G2 Liver | 1401 / 11891 (11.8%) | 5369 / 118910 (4.5%) | −197.1 | −194.3 | 2.61 |
| SMARCA4 SRX5075176 | Neural progenitor cells Neural | 424 / 11891 (3.6%) | 13544 / 118910 (11.4%) | −194.4 | −191.6 | 0.31 |
| FOXA1 SRX176862 | MCF-7 Breast | 213 / 11891 (1.8%) | 9805 / 118910 (8.2%) | −191.5 | −188.7 | 0.22 |
| FOXA1 SRX4815197 | MCF-7 Breast | 464 / 11891 (3.9%) | 14046 / 118910 (11.8%) | −190.1 | −187.3 | 0.33 |
| JUNB SRX8488088 | SUM 229PE Breast | 351 / 11891 (3.0%) | 12020 / 118910 (10.1%) | −184.1 | −181.3 | 0.29 |
| FOXA1 SRX176863 | MCF-7 Breast | 202 / 11891 (1.7%) | 9348 / 118910 (7.9%) | −182.8 | −180.0 | 0.22 |
| ESR1 SRX4367193 | MCF-7 Breast | 656 / 11891 (5.5%) | 16698 / 118910 (14.0%) | −182.2 | −179.4 | 0.39 |
| FOXA1 SRX3931044 | MCF-7 Breast | 415 / 11891 (3.5%) | 12988 / 118910 (10.9%) | −181.5 | −178.8 | 0.32 |
| FOS SRX150517 | MCF 10A Breast | 309 / 11891 (2.6%) | 11212 / 118910 (9.4%) | −180.8 | −178.1 | 0.28 |
| RELA SRX2207673 | HUVEC Cardiovascular | 745 / 11891 (6.3%) | 17931 / 118910 (15.1%) | −180.7 | −178.0 | 0.42 |
| SMARCA4 SRX5075170 | Neural progenitor cells Neural | 468 / 11891 (3.9%) | 13780 / 118910 (11.6%) | −180.0 | −177.3 | 0.34 |
| SMARCA2 SRX8119674 | MRC-5 Lung | 467 / 11891 (3.9%) | 13697 / 118910 (11.5%) | −178.0 | −175.3 | 0.34 |
| YAP1 SRX5718140 | 293 Kidney | 309 / 11891 (2.6%) | 11102 / 118910 (9.3%) | −177.4 | −174.6 | 0.28 |
| ESR1 SRX7624157 | MCF-7 Breast | 517 / 11891 (4.3%) | 14442 / 118910 (12.1%) | −177.0 | −174.3 | 0.36 |
| BRD4 SRX736204 | 90-8TL Neural | 781 / 11891 (6.6%) | 2095 / 118910 (1.8%) | −176.9 | −174.2 | 3.73 |
| AR SRX1067071 | LHSAR Prostate | 379 / 11891 (3.2%) | 12226 / 118910 (10.3%) | −175.9 | −173.2 | 0.31 |
| ESR1 SRX371478 | MCF-7 Breast | 231 / 11891 (1.9%) | 9675 / 118910 (8.1%) | −175.6 | −172.9 | 0.24 |
| SMARCA2 SRX8119677 | MeT-5A Others | 300 / 11891 (2.5%) | 10874 / 118910 (9.1%) | −174.9 | −172.2 | 0.28 |
| GATA3 SRX190239 | MCF-7 Breast | 274 / 11891 (2.3%) | 10372 / 118910 (8.7%) | −173.2 | −170.5 | 0.26 |
| FOXA1 SRX9419950 | SK-BR-3 Breast | 327 / 11891 (2.7%) | 11272 / 118910 (9.5%) | −173.0 | −170.4 | 0.29 |
| JUN SRX11051031 | hTERT RPE-1 Neural | 706 / 11891 (5.9%) | 17082 / 118910 (14.4%) | −172.6 | −169.9 | 0.41 |
| CARM1 SRX10562203 | MDA-MB-231 Breast | 237 / 11891 (2.0%) | 84 / 118910 (0.1%) | −172.3 | −169.6 | 28.21 |
| JUN SRX11051032 | hTERT RPE-1 Neural | 700 / 11891 (5.9%) | 16953 / 118910 (14.3%) | −171.4 | −168.8 | 0.41 |
| SMARCA4 SRX5075169 | Neural progenitor cells Neural | 378 / 11891 (3.2%) | 12033 / 118910 (10.1%) | −170.3 | −167.7 | 0.31 |
| RELA SRX2207672 | HUVEC Cardiovascular | 835 / 11891 (7.0%) | 18804 / 118910 (15.8%) | −170.0 | −167.4 | 0.44 |
| FOS SRX150476 | MCF 10A Breast | 332 / 11891 (2.8%) | 11235 / 118910 (9.4%) | −169.2 | −166.6 | 0.30 |
| RUNX1 SRX2513054 | 293 Kidney | 2344 / 11891 (19.7%) | 12562 / 118910 (10.6%) | −168.7 | −166.1 | 1.87 |
| NCOA3 SRX8949281 | ZR-75-1 Breast | 210 / 11891 (1.8%) | 9063 / 118910 (7.6%) | −167.9 | −165.3 | 0.23 |
| FOXA1 SRX371482 | MCF-7 Breast | 277 / 11891 (2.3%) | 10253 / 118910 (8.6%) | −167.6 | −165.0 | 0.27 |
| FOXA1 SRX1161177 | MCF-7 Breast | 181 / 11891 (1.5%) | 8490 / 118910 (7.1%) | −167.0 | −164.4 | 0.21 |
| GATA3 SRX190194 | SK-N-SH Neural | 483 / 11891 (4.1%) | 13561 / 118910 (11.4%) | −166.4 | −163.8 | 0.36 |
| FOXA1 SRX371481 | MCF-7 Breast | 192 / 11891 (1.6%) | 8671 / 118910 (7.3%) | −166.0 | −163.4 | 0.22 |
| FOXA1 SRX9419949 | SK-BR-3 Breast | 273 / 11891 (2.3%) | 10104 / 118910 (8.5%) | −165.0 | −162.4 | 0.27 |
| ESR1 SRX20282961 | MCF-7 Breast | 243 / 11891 (2.0%) | 9563 / 118910 (8.0%) | −164.6 | −162.0 | 0.25 |
| AR SRX10820653 | LNCAP Prostate | 262 / 11891 (2.2%) | 149 / 118910 (0.1%) | −164.5 | −161.9 | 17.58 |
| FOXA2 SRX5504125 | CFPAC-1 Pancreas | 226 / 11891 (1.9%) | 9242 / 118910 (7.8%) | −164.1 | −161.5 | 0.24 |
| NANOG SRX3288566 | hESC H9 Pluripotent stem cell | 124 / 11891 (1.0%) | 7274 / 118910 (6.1%) | −164.0 | −161.5 | 0.17 |
| SMARCC1 SRX11379507 | Liposarcoma, Myxoid Adipocyte | 431 / 11891 (3.6%) | 12653 / 118910 (10.6%) | −163.5 | −160.9 | 0.34 |
| NCOA3 SRX8949280 | ZR-75-1 Breast | 222 / 11891 (1.9%) | 9133 / 118910 (7.7%) | −162.9 | −160.4 | 0.24 |
| HMGB1 SRX10567335 | HUVEC Cardiovascular | 1058 / 11891 (8.9%) | 3824 / 118910 (3.2%) | −161.4 | −158.9 | 2.77 |
| AR SRX1067070 | LHSAR Prostate | 519 / 11891 (4.4%) | 13932 / 118910 (11.7%) | −161.3 | −158.8 | 0.37 |
| TCF12 SRX190356 | SK-N-SH Neural | 581 / 11891 (4.9%) | 14857 / 118910 (12.5%) | −161.3 | −158.7 | 0.39 |
| FOXA1 SRX371483 | MCF-7 Breast | 214 / 11891 (1.8%) | 8929 / 118910 (7.5%) | −161.0 | −158.4 | 0.24 |
| 5-mC SRX882970 | LNCAP Prostate | 2085 / 11891 (17.5%) | 10830 / 118910 (9.1%) | −160.7 | −158.2 | 1.93 |
| ESR1 SRX371479 | MCF-7 Breast | 171 / 11891 (1.4%) | 8079 / 118910 (6.8%) | −159.4 | −156.8 | 0.21 |
| EED SRX8175103 | ES cells Pluripotent stem cell | 1519 / 11891 (12.8%) | 6841 / 118910 (5.8%) | −158.5 | −155.9 | 2.22 |
| JUN SRX17561461 | LPS141 Adipocyte | 289 / 11891 (2.4%) | 10158 / 118910 (8.5%) | −158.0 | −155.5 | 0.28 |
| ESR1 SRX371469 | MCF-7 Breast | 202 / 11891 (1.7%) | 8609 / 118910 (7.2%) | −157.6 | −155.1 | 0.23 |
| ESR1 SRX7624156 | MCF-7 Breast | 330 / 11891 (2.8%) | 10808 / 118910 (9.1%) | −156.8 | −154.3 | 0.31 |
| FOXA2 SRX6441753 | CFPAC-1 Pancreas | 249 / 11891 (2.1%) | 9424 / 118910 (7.9%) | −156.5 | −154.0 | 0.26 |
| JUN SRX4192884 | MCF 10A Breast | 136 / 11891 (1.1%) | 7302 / 118910 (6.1%) | −156.3 | −153.8 | 0.19 |
| JUNB SRX8488073 | SUM 229PE Breast | 388 / 11891 (3.3%) | 11715 / 118910 (9.9%) | −155.8 | −153.3 | 0.33 |
| VGLL1 SRX24602130 | BT-20 Breast | 191 / 11891 (1.6%) | 8331 / 118910 (7.0%) | −155.0 | −152.5 | 0.23 |
| TLE3 SRX4815191 | MCF-7 Breast | 185 / 11891 (1.6%) | 8214 / 118910 (6.9%) | −154.8 | −152.3 | 0.23 |
| FOSL1 SRX14181206 | MSK-PCa3 Prostate | 354 / 11891 (3.0%) | 11132 / 118910 (9.4%) | −154.6 | −152.1 | 0.32 |
| TP53 SRX19538272 | U2OS Bone | 456 / 11891 (3.8%) | 800 / 118910 (0.7%) | −154.6 | −152.1 | 5.70 |
| FOXA1 SRX9419951 | SK-BR-3 Breast | 255 / 11891 (2.1%) | 9448 / 118910 (7.9%) | −154.0 | −151.5 | 0.27 |
| FOXA1 SRX1161173 | MCF-7 Breast | 147 / 11891 (1.2%) | 7442 / 118910 (6.3%) | −153.4 | −150.9 | 0.20 |
| CEBPB SRX150632 | HeLa Uterus | 486 / 11891 (4.1%) | 13135 / 118910 (11.0%) | −152.8 | −150.3 | 0.37 |
| SS18 SRX3468047 | Fibroblasts Others | 556 / 11891 (4.7%) | 14175 / 118910 (11.9%) | −152.5 | −150.0 | 0.39 |
| 5-mC SRX882968 | LNCAP Prostate | 2045 / 11891 (17.2%) | 10774 / 118910 (9.1%) | −151.5 | −149.0 | 1.90 |
| FOS SRX4192879 | MCF 10A Breast | 223 / 11891 (1.9%) | 8787 / 118910 (7.4%) | −150.7 | −148.3 | 0.25 |
| ESR1 SRX371471 | ZR-75-1 Breast | 218 / 11891 (1.8%) | 8680 / 118910 (7.3%) | −150.3 | −147.8 | 0.25 |
| NCOA3 SRX8949279 | ZR-75-1 Breast | 308 / 11891 (2.6%) | 10233 / 118910 (8.6%) | −150.3 | −147.8 | 0.30 |
| FOXA1 SRX1161187 | ZR-75-1 Breast | 188 / 11891 (1.6%) | 8109 / 118910 (6.8%) | −149.5 | −147.0 | 0.23 |
| SMARCA4 SRX5212366 | Mel270 Others | 271 / 11891 (2.3%) | 9561 / 118910 (8.0%) | −148.8 | −146.3 | 0.28 |
| FOXA1 SRX8537740 | SUM 44PE Breast | 487 / 11891 (4.1%) | 12978 / 118910 (10.9%) | −147.8 | −145.4 | 0.38 |
| DNMT3B SRX3275108 | iPS cells Pluripotent stem cell | 352 / 11891 (3.0%) | 458 / 118910 (0.4%) | −147.8 | −145.3 | 7.69 |
| FOXA1 SRX1161176 | MCF-7 Breast | 194 / 11891 (1.6%) | 8157 / 118910 (6.9%) | −147.4 | −144.9 | 0.24 |
| ESR1 SRX20282960 | MCF-7 Breast | 240 / 11891 (2.0%) | 8971 / 118910 (7.5%) | −147.0 | −144.6 | 0.27 |
| SMARCA4 SRX5212357 | Mel270 Others | 298 / 11891 (2.5%) | 9955 / 118910 (8.4%) | −146.8 | −144.4 | 0.30 |
| ARID5B SRX3230377 | Hep G2 Liver | 558 / 11891 (4.7%) | 13985 / 118910 (11.8%) | −146.4 | −144.0 | 0.40 |
| FOSL2 SRX10640866 | SK-MEL-147 Epidermis | 421 / 11891 (3.5%) | 11912 / 118910 (10.0%) | −146.2 | −143.8 | 0.35 |
| ESR1 SRX20282939 | MCF-7 Breast | 239 / 11891 (2.0%) | 8929 / 118910 (7.5%) | −146.2 | −143.7 | 0.27 |
| FOXA1 SRX100454 | T-47D Breast | 272 / 11891 (2.3%) | 9486 / 118910 (8.0%) | −145.8 | −143.4 | 0.29 |
| ESR1 SRX176861 | MCF-7 Breast | 368 / 11891 (3.1%) | 11063 / 118910 (9.3%) | −145.8 | −143.3 | 0.33 |
| JUN SRX11051045 | hTERT RPE-1 Neural | 728 / 11891 (6.1%) | 16372 / 118910 (13.8%) | −145.2 | −142.7 | 0.44 |
| YY1 SRX13585223 | NCCIT Pluripotent stem cell | 870 / 11891 (7.3%) | 2955 / 118910 (2.5%) | −145.0 | −142.6 | 2.94 |
| JUN SRX11051046 | hTERT RPE-1 Neural | 649 / 11891 (5.5%) | 15248 / 118910 (12.8%) | −145.0 | −142.6 | 0.43 |
| FOXA1 SRX1161175 | MCF-7 Breast | 143 / 11891 (1.2%) | 7114 / 118910 (6.0%) | −144.8 | −142.4 | 0.20 |
| FOXA1 SRX1161174 | MCF-7 Breast | 208 / 11891 (1.7%) | 8334 / 118910 (7.0%) | −144.8 | −142.4 | 0.25 |
| ESR1 SRX176860 | MCF-7 Breast | 365 / 11891 (3.1%) | 10979 / 118910 (9.2%) | −144.6 | −142.2 | 0.33 |
| TEAD1 SRX3401272 | MCF-7 Breast | 139 / 11891 (1.2%) | 7020 / 118910 (5.9%) | −144.3 | −141.9 | 0.20 |
| ESR1 SRX371470 | ZR-75-1 Breast | 182 / 11891 (1.5%) | 7843 / 118910 (6.6%) | −144.2 | −141.8 | 0.23 |
| ESR1 SRX371467 | MCF-7 Breast | 218 / 11891 (1.8%) | 8485 / 118910 (7.1%) | −143.9 | −141.5 | 0.26 |
| WWTR1 SRX10119367 | MCF 10A Breast | 238 / 11891 (2.0%) | 8831 / 118910 (7.4%) | −143.7 | −141.3 | 0.27 |
| SMARCA4 SRX5212362 | Mel270 Others | 375 / 11891 (3.2%) | 11101 / 118910 (9.3%) | −143.6 | −141.2 | 0.34 |
| FOXA1 SRX6441749 | CFPAC-1 Pancreas | 174 / 11891 (1.5%) | 7671 / 118910 (6.5%) | −143.5 | −141.1 | 0.23 |
| JUNB SRX10119396 | MDA-MB-231 Breast | 201 / 11891 (1.7%) | 8158 / 118910 (6.9%) | −143.1 | −140.7 | 0.25 |
| DNMT3B SRX2862488 | hESC HUES8 Pluripotent stem cell | 360 / 11891 (3.0%) | 509 / 118910 (0.4%) | −143.1 | −140.7 | 7.07 |
| ESR1 SRX194569 | MCF-7 Breast | 220 / 11891 (1.9%) | 8487 / 118910 (7.1%) | −142.7 | −140.4 | 0.26 |
| FOXA2 SRX6441752 | CFPAC-1 Pancreas | 216 / 11891 (1.8%) | 8409 / 118910 (7.1%) | −142.5 | −140.1 | 0.26 |
| FOXA1 SRX1161190 | ZR-75-1 Breast | 180 / 11891 (1.5%) | 7744 / 118910 (6.5%) | −142.2 | −139.9 | 0.23 |
| FOXA1 SRX1161189 | ZR-75-1 Breast | 183 / 11891 (1.5%) | 7799 / 118910 (6.6%) | −142.1 | −139.8 | 0.23 |
| JUNB SRX8488089 | SUM 229PE Breast | 197 / 11891 (1.7%) | 8054 / 118910 (6.8%) | −142.1 | −139.7 | 0.24 |
| FOXA1 SRX15430994 | SK-BR-3 Breast | 203 / 11891 (1.7%) | 8144 / 118910 (6.8%) | −141.4 | −139.1 | 0.25 |
| SMARCC1 SRX11379505 | Liposarcoma, Myxoid Adipocyte | 388 / 11891 (3.3%) | 11233 / 118910 (9.4%) | −141.4 | −139.0 | 0.35 |
| STAT3 SRX2020842 | HCC70 Breast | 394 / 11891 (3.3%) | 11316 / 118910 (9.5%) | −141.1 | −138.8 | 0.35 |
| FOSL2 SRX10640865 | SK-MEL-147 Epidermis | 432 / 11891 (3.6%) | 11899 / 118910 (10.0%) | −140.9 | −138.6 | 0.36 |
| FOXA1 SRX371480 | MCF-7 Breast | 132 / 11891 (1.1%) | 6777 / 118910 (5.7%) | −140.6 | −138.3 | 0.19 |
| SMARCA4 SRX5075175 | Neural progenitor cells Neural | 324 / 11891 (2.7%) | 10181 / 118910 (8.6%) | −140.6 | −138.2 | 0.32 |
| PRRX1 SRX15235713 | Hs 578T Breast | 256 / 11891 (2.2%) | 9036 / 118910 (7.6%) | −140.3 | −137.9 | 0.28 |
| SMARCA4 SRX5212371 | Mel270 Others | 304 / 11891 (2.6%) | 9840 / 118910 (8.3%) | −140.2 | −137.8 | 0.31 |
| JUNB SRX10119386 | MCF 10A Breast | 176 / 11891 (1.5%) | 7608 / 118910 (6.4%) | −140.1 | −137.7 | 0.23 |
| STAT5B SRX831881 | CD8+ T cells Blood | 211 / 11891 (1.8%) | 103 / 118910 (0.1%) | −139.7 | −137.3 | 20.49 |
| FOXA1 SRX11222441 | MCF-7 Breast | 148 / 11891 (1.2%) | 7046 / 118910 (5.9%) | −139.1 | −136.8 | 0.21 |
| EED SRX8175102 | ES cells Pluripotent stem cell | 1257 / 11891 (10.6%) | 5477 / 118910 (4.6%) | −138.5 | −136.2 | 2.30 |
| FOXL2 SRX6957431 | KGN Gonad | 534 / 11891 (4.5%) | 13334 / 118910 (11.2%) | −138.2 | −135.9 | 0.40 |
| FOXA2 SRX3230382 | Hep G2 Liver | 297 / 11891 (2.5%) | 9649 / 118910 (8.1%) | −137.9 | −135.6 | 0.31 |
| AR SRX10820651 | LNCAP Prostate | 264 / 11891 (2.2%) | 234 / 118910 (0.2%) | −137.5 | −135.2 | 11.28 |
| FOXA1 SRX100506 | Hep G2 Liver | 295 / 11891 (2.5%) | 9590 / 118910 (8.1%) | −137.0 | −134.7 | 0.31 |
| ESR1 SRX371476 | MCF-7 Breast | 155 / 11891 (1.3%) | 7124 / 118910 (6.0%) | −137.0 | −134.7 | 0.22 |
| FOXA1 SRX825395 | CFPAC-1 Pancreas | 192 / 11891 (1.6%) | 7806 / 118910 (6.6%) | −136.9 | −134.6 | 0.25 |
| ARID1A SRX5089376 | MCF-7 Breast | 179 / 11891 (1.5%) | 7571 / 118910 (6.4%) | −136.9 | −134.6 | 0.24 |
| EP300 SRX2194266 | SUM 159PT Breast | 392 / 11891 (3.3%) | 11136 / 118910 (9.4%) | −136.8 | −134.5 | 0.35 |
| PBX3 SRX190343 | SK-N-SH Neural | 483 / 11891 (4.1%) | 12513 / 118910 (10.5%) | −136.4 | −134.1 | 0.39 |
| FOXA1 SRX8537741 | SUM 44PE Breast | 378 / 11891 (3.2%) | 10896 / 118910 (9.2%) | −136.2 | −133.9 | 0.35 |
| ESR1 SRX194572 | MCF-7 Breast | 125 / 11891 (1.1%) | 6511 / 118910 (5.5%) | −136.2 | −133.9 | 0.19 |
| FOSL2 SRX5054309 | Neural progenitor cells Neural | 211 / 11891 (1.8%) | 8124 / 118910 (6.8%) | −136.1 | −133.9 | 0.26 |
| ESR1 SRX1531791 | MCF-7 Breast | 210 / 11891 (1.8%) | 8089 / 118910 (6.8%) | −135.6 | −133.3 | 0.26 |
| ESR1 SRX371468 | MCF-7 Breast | 126 / 11891 (1.1%) | 6510 / 118910 (5.5%) | −135.4 | −133.2 | 0.19 |
| ESR1 SRX20282954 | MCF-7 Breast | 243 / 11891 (2.0%) | 8648 / 118910 (7.3%) | −135.0 | −132.7 | 0.28 |
| STAT3 SRX150479 | MCF 10A Breast | 191 / 11891 (1.6%) | 7722 / 118910 (6.5%) | −134.7 | −132.5 | 0.25 |
| FOXA1 SRX1161192 | ZR-75-1 Breast | 194 / 11891 (1.6%) | 7776 / 118910 (6.5%) | −134.7 | −132.4 | 0.25 |
| 5-mC SRX882965 | LNCAP Prostate | 1663 / 11891 (14.0%) | 8392 / 118910 (7.1%) | −134.6 | −132.3 | 1.98 |
| NR2F2 SRX190293 | MCF-7 Breast | 228 / 11891 (1.9%) | 8377 / 118910 (7.0%) | −134.6 | −132.3 | 0.27 |
| CEBPB SRX11379528 | Liposarcoma, Myxoid Adipocyte | 535 / 11891 (4.5%) | 13214 / 118910 (11.1%) | −134.6 | −132.3 | 0.40 |
| FOXA1 SRX3931043 | MCF-7 Breast | 219 / 11891 (1.8%) | 8217 / 118910 (6.9%) | −134.5 | −132.3 | 0.27 |
| YAP1 SRX10119364 | MCF 10A Breast | 172 / 11891 (1.4%) | 7354 / 118910 (6.2%) | −134.1 | −131.8 | 0.23 |
| ATF1 SRX11470446 | Mesenchymal stem cells Others | 599 / 11891 (5.0%) | 14110 / 118910 (11.9%) | −133.7 | −131.5 | 0.42 |
| SMARCC1 SRX11379504 | Liposarcoma, Myxoid Adipocyte | 687 / 11891 (5.8%) | 15348 / 118910 (12.9%) | −133.5 | −131.2 | 0.45 |
| JUNB SRX8488074 | SUM 229PE Breast | 294 / 11891 (2.5%) | 9458 / 118910 (8.0%) | −133.5 | −131.2 | 0.31 |
| RELA SRX5938177 | FaDu Others | 192 / 11891 (1.6%) | 7704 / 118910 (6.5%) | −133.4 | −131.2 | 0.25 |
| Epitope tags SRX5877912 | U2OS Bone | 1377 / 11891 (11.6%) | 24362 / 118910 (20.5%) | −133.4 | −131.2 | 0.57 |
| CEBPB SRX11379518 | Liposarcoma, Myxoid Adipocyte | 604 / 11891 (5.1%) | 1654 / 118910 (1.4%) | −132.8 | −130.6 | 3.65 |
| JUNB SRX10119395 | MDA-MB-231 Breast | 191 / 11891 (1.6%) | 7657 / 118910 (6.4%) | −132.6 | −130.4 | 0.25 |
| ESR1 SRX4367192 | MCF-7 Breast | 479 / 11891 (4.0%) | 12313 / 118910 (10.4%) | −132.5 | −130.2 | 0.39 |
| STAT3 SRX150630 | MCF 10A Breast | 193 / 11891 (1.6%) | 7688 / 118910 (6.5%) | −132.3 | −130.1 | 0.25 |
| FOXA1 SRX6441747 | CFPAC-1 Pancreas | 195 / 11891 (1.6%) | 7715 / 118910 (6.5%) | −132.1 | −129.8 | 0.25 |
| ESR1 SRX20282972 | MCF-7 Breast | 255 / 11891 (2.1%) | 8756 / 118910 (7.4%) | −132.0 | −129.7 | 0.29 |
| ARID1A SRX5089379 | MCF-7 Breast | 215 / 11891 (1.8%) | 8066 / 118910 (6.8%) | −131.9 | −129.7 | 0.27 |
| EP300 SRX150579 | HeLa Uterus | 128 / 11891 (1.1%) | 6446 / 118910 (5.4%) | −131.7 | −129.5 | 0.20 |
| FOXA2 SRX6441750 | CFPAC-1 Pancreas | 191 / 11891 (1.6%) | 7623 / 118910 (6.4%) | −131.4 | −129.2 | 0.25 |
| DNA-RNA hybrid SRX21658478 | U2OS Bone | 462 / 11891 (3.9%) | 991 / 118910 (0.8%) | −131.3 | −129.1 | 4.66 |
| FOXA1 SRX1787653 | MCF-7 Breast | 175 / 11891 (1.5%) | 7325 / 118910 (6.2%) | −131.3 | −129.0 | 0.24 |
| ESR2 SRX8272750 | HT-29 Digestive tract | 389 / 11891 (3.3%) | 687 / 118910 (0.6%) | −131.0 | −128.8 | 5.66 |
| FOSL2 SRX10640867 | SK-MEL-147 Epidermis | 400 / 11891 (3.4%) | 11057 / 118910 (9.3%) | −131.0 | −128.7 | 0.36 |
| EP300 SRX2194265 | SUM 159PT Breast | 361 / 11891 (3.0%) | 10449 / 118910 (8.8%) | −130.9 | −128.7 | 0.35 |
| SMARCC1 SRX11379511 | Liposarcoma, Myxoid Adipocyte | 301 / 11891 (2.5%) | 9485 / 118910 (8.0%) | −130.8 | −128.6 | 0.32 |
| FOSL2 SRX3367141 | SK-MEL-147 Epidermis | 317 / 11891 (2.7%) | 9743 / 118910 (8.2%) | −130.7 | −128.5 | 0.33 |
| FOXA1 SRX15430993 | SK-BR-3 Breast | 193 / 11891 (1.6%) | 7634 / 118910 (6.4%) | −130.7 | −128.5 | 0.25 |
| NKX2-1 SRX2164786 | A549 Lung | 378 / 11891 (3.2%) | 10687 / 118910 (9.0%) | −130.1 | −127.9 | 0.35 |
| GATAD2A SRX2636506 | Hep G2 Liver | 288 / 11891 (2.4%) | 9245 / 118910 (7.8%) | −130.0 | −127.8 | 0.31 |
| JUNB SRX4192882 | MCF 10A Breast | 166 / 11891 (1.4%) | 7118 / 118910 (6.0%) | −129.9 | −127.7 | 0.23 |
| TP53 SRX2585782 | MDA-MB-231 Breast | 434 / 11891 (3.6%) | 11540 / 118910 (9.7%) | −129.8 | −127.6 | 0.38 |
| CIC SRX13262055 | Astrocytes Neural | 2102 / 11891 (17.7%) | 11818 / 118910 (9.9%) | −129.8 | −127.6 | 1.78 |
| FOXA1 SRX3931055 | MCF-7 Breast | 183 / 11891 (1.5%) | 7429 / 118910 (6.2%) | −129.8 | −127.6 | 0.25 |
| JUN SRX883584 | MDA-MB-231 Breast | 366 / 11891 (3.1%) | 10484 / 118910 (8.8%) | −129.7 | −127.5 | 0.35 |
| ESR1 SRX20282973 | MCF-7 Breast | 278 / 11891 (2.3%) | 9064 / 118910 (7.6%) | −129.6 | −127.4 | 0.31 |
| NR1H3 SRX1538760 | HT-29 Digestive tract | 200 / 11891 (1.7%) | 7725 / 118910 (6.5%) | −129.5 | −127.4 | 0.26 |
| Epitope tags SRX10549776 | K-562 Blood | 971 / 11891 (8.2%) | 3794 / 118910 (3.2%) | −129.5 | −127.3 | 2.56 |
| JUNB SRX10119383 | MCF 10A Breast | 135 / 11891 (1.1%) | 6510 / 118910 (5.5%) | −129.3 | −127.1 | 0.21 |
| FOXA1 SRX11222442 | MCF-7 Breast | 135 / 11891 (1.1%) | 6505 / 118910 (5.5%) | −129.1 | −126.9 | 0.21 |
| SOX13 SRX2636248 | Hep G2 Liver | 319 / 11891 (2.7%) | 9718 / 118910 (8.2%) | −129.0 | −126.8 | 0.33 |
| TAZ SRX14181208 | MSK-PCa3 Prostate | 232 / 11891 (2.0%) | 8264 / 118910 (6.9%) | −128.8 | −126.6 | 0.28 |
| FOXA1 SRX1389381 | CFPAC-1 Pancreas | 187 / 11891 (1.6%) | 7462 / 118910 (6.3%) | −128.5 | −126.3 | 0.25 |
| FOXA1 SRX1161188 | ZR-75-1 Breast | 150 / 11891 (1.3%) | 6772 / 118910 (5.7%) | −128.3 | −126.1 | 0.22 |
| FOXA1 SRX3923514 | MCF-7 Breast | 231 / 11891 (1.9%) | 8230 / 118910 (6.9%) | −128.3 | −126.1 | 0.28 |
| NANOG SRX20532160 | hESC HUES8 Pluripotent stem cell | 736 / 11891 (6.2%) | 15816 / 118910 (13.3%) | −128.2 | −126.1 | 0.47 |
| STAT3 SRX150536 | MCF 10A Breast | 252 / 11891 (2.1%) | 8581 / 118910 (7.2%) | −128.1 | −126.0 | 0.29 |
| FOXA1 SRX9419952 | SK-BR-3 Breast | 209 / 11891 (1.8%) | 7818 / 118910 (6.6%) | −127.5 | −125.3 | 0.27 |
| GATA3 SRX5057632 | MCF-7 Breast | 143 / 11891 (1.2%) | 6611 / 118910 (5.6%) | −127.4 | −125.2 | 0.22 |
| NANOG SRX20532161 | hESC HUES8 Pluripotent stem cell | 641 / 11891 (5.4%) | 14458 / 118910 (12.2%) | −127.3 | −125.2 | 0.44 |
| SMARCA4 SRX8588624 | Pulmonary artery endothelial cells Cardiovascular | 414 / 11891 (3.5%) | 11126 / 118910 (9.4%) | −126.8 | −124.6 | 0.37 |
| FOXA2 SRX100448 | Hep G2 Liver | 256 / 11891 (2.2%) | 8598 / 118910 (7.2%) | −126.6 | −124.4 | 0.30 |
| JUN SRX6582171 | GM07492 Others | 469 / 11891 (3.9%) | 11940 / 118910 (10.0%) | −126.3 | −124.2 | 0.39 |
| FOXA1 SRX1447317 | MCF-7 Breast | 134 / 11891 (1.1%) | 6403 / 118910 (5.4%) | −126.3 | −124.1 | 0.21 |
| JUND SRX150408 | HeLa Uterus | 190 / 11891 (1.6%) | 7444 / 118910 (6.3%) | −126.2 | −124.1 | 0.26 |
| EP300 SRX2671813 | Fibroblasts Others | 184 / 11891 (1.5%) | 7333 / 118910 (6.2%) | −126.1 | −124.0 | 0.25 |
| AGO2 SRX6783957 | Hep G2 Liver | 873 / 11891 (7.3%) | 3250 / 118910 (2.7%) | −126.1 | −123.9 | 2.69 |
| FOS SRX3322636 | MCF-7 Breast | 132 / 11891 (1.1%) | 6355 / 118910 (5.3%) | −126.0 | −123.8 | 0.21 |
| RAC1 SRX10365541 | MCF-7 Breast | 110 / 11891 (0.9%) | 5917 / 118910 (5.0%) | −126.0 | −123.8 | 0.19 |
| FOXA1 SRX3931054 | MCF-7 Breast | 212 / 11891 (1.8%) | 7820 / 118910 (6.6%) | −125.8 | −123.7 | 0.27 |
| FOSL2 SRX190296 | SK-N-SH Neural | 310 / 11891 (2.6%) | 9462 / 118910 (8.0%) | −125.7 | −123.6 | 0.33 |
| RAC1 SRX10365543 | MCF-7 Breast | 109 / 11891 (0.9%) | 5888 / 118910 (5.0%) | −125.6 | −123.5 | 0.19 |
| GATA3 SRX176864 | MCF-7 Breast | 165 / 11891 (1.4%) | 6969 / 118910 (5.9%) | −125.6 | −123.4 | 0.24 |
| ESR1 SRX2943591 | MCF-7 Breast | 154 / 11891 (1.3%) | 6762 / 118910 (5.7%) | −125.5 | −123.4 | 0.23 |
| SMARCC1 SRX11379506 | Liposarcoma, Myxoid Adipocyte | 404 / 11891 (3.4%) | 10921 / 118910 (9.2%) | −125.3 | −123.2 | 0.37 |
| JUND SRX190357 | SK-N-SH Neural | 290 / 11891 (2.4%) | 9114 / 118910 (7.7%) | −125.2 | −123.0 | 0.32 |
| AGO2 SRX6783958 | Hep G2 Liver | 864 / 11891 (7.3%) | 3210 / 118910 (2.7%) | −125.1 | −123.0 | 2.69 |
| TEAD3 SRX2636153 | Hep G2 Liver | 591 / 11891 (5.0%) | 13665 / 118910 (11.5%) | −125.0 | −122.9 | 0.43 |
| ESR1 SRX10365536 | MCF-7 Breast | 109 / 11891 (0.9%) | 5872 / 118910 (4.9%) | −125.0 | −122.9 | 0.19 |
| FOXA1 SRX028634 | MCF-7 Breast | 97 / 11891 (0.8%) | 5615 / 118910 (4.7%) | −124.7 | −122.6 | 0.17 |
| NR3C1 SRX17639412 | A549 Lung | 255 / 11891 (2.1%) | 8508 / 118910 (7.2%) | −124.3 | −122.2 | 0.30 |
| GATA3 SRX5457550 | MCF-7 Breast | 263 / 11891 (2.2%) | 8640 / 118910 (7.3%) | −124.3 | −122.1 | 0.30 |
| ESR1 SRX20282955 | MCF-7 Breast | 249 / 11891 (2.1%) | 8397 / 118910 (7.1%) | −124.0 | −121.9 | 0.30 |
| SS18 SRX10640843 | SK-MEL-147 Epidermis | 377 / 11891 (3.2%) | 10456 / 118910 (8.8%) | −123.9 | −121.7 | 0.36 |
| ARID5B SRX10475138 | Hep G2 Liver | 403 / 11891 (3.4%) | 10841 / 118910 (9.1%) | −123.6 | −121.4 | 0.37 |
| ESR1 SRX2881002 | MCF-7 Breast | 216 / 11891 (1.8%) | 7810 / 118910 (6.6%) | −123.3 | −121.2 | 0.28 |
| SS18 SRX10881848 | G-401 Kidney | 322 / 11891 (2.7%) | 9565 / 118910 (8.0%) | −123.2 | −121.0 | 0.34 |
| FOXA1 SRX1161191 | ZR-75-1 Breast | 178 / 11891 (1.5%) | 7130 / 118910 (6.0%) | −123.0 | −120.9 | 0.25 |
| FOXA1 SRX1161203 | T-47D Breast | 158 / 11891 (1.3%) | 6749 / 118910 (5.7%) | −122.6 | −120.5 | 0.23 |
| NANOG SRX10448024 | hESC H1 Pluripotent stem cell | 886 / 11891 (7.5%) | 17597 / 118910 (14.8%) | −122.5 | −120.3 | 0.50 |
| JUN SRX6582172 | Fibroblasts Others | 316 / 11891 (2.7%) | 9444 / 118910 (7.9%) | −122.3 | −120.2 | 0.33 |
| FOXA1 SRX5124035 | 22Rv1 Prostate | 307 / 11891 (2.6%) | 9297 / 118910 (7.8%) | −122.3 | −120.2 | 0.33 |
| ESR1 SRX10365535 | MCF-7 Breast | 184 / 11891 (1.5%) | 7213 / 118910 (6.1%) | −122.2 | −120.1 | 0.26 |
| DAXX SRX1021630 | PC-3 Prostate | 229 / 11891 (1.9%) | 8001 / 118910 (6.7%) | −122.2 | −120.1 | 0.29 |
| ARID5B SRX10475139 | Hep G2 Liver | 254 / 11891 (2.1%) | 8424 / 118910 (7.1%) | −122.2 | −120.1 | 0.30 |
| SS18 SRX10640842 | SK-MEL-147 Epidermis | 307 / 11891 (2.6%) | 9289 / 118910 (7.8%) | −122.2 | −120.0 | 0.33 |
| ESR1 SRX8537722 | MCF-7 Breast | 213 / 11891 (1.8%) | 7720 / 118910 (6.5%) | −122.1 | −120.0 | 0.28 |
| CHD7 SRX3581507 | iPS cells Pluripotent stem cell | 181 / 11891 (1.5%) | 7153 / 118910 (6.0%) | −121.9 | −119.8 | 0.25 |
| FOXA1 SRX11222437 | MCF-7 Breast | 163 / 11891 (1.4%) | 6819 / 118910 (5.7%) | −121.8 | −119.7 | 0.24 |
| Epitope tags SRX8080565 | Mammary gland adenocarcinoma Breast | 101 / 11891 (0.8%) | 5610 / 118910 (4.7%) | −121.6 | −119.5 | 0.18 |
| FOXA1 SRX3923533 | ZR-75-1 Breast | 258 / 11891 (2.2%) | 8463 / 118910 (7.1%) | −121.4 | −119.3 | 0.30 |
| ESR1 SRX2881000 | MCF-7 Breast | 204 / 11891 (1.7%) | 7539 / 118910 (6.3%) | −121.3 | −119.2 | 0.27 |
| ESR1 SRX20282940 | MCF-7 Breast | 262 / 11891 (2.2%) | 8516 / 118910 (7.2%) | −121.0 | −118.9 | 0.31 |
| ESR1 SRX371475 | BT-474 Breast | 105 / 11891 (0.9%) | 5671 / 118910 (4.8%) | −120.9 | −118.8 | 0.19 |
| TP53 SRX3102569 | SW 480 Digestive tract | 484 / 11891 (4.1%) | 11962 / 118910 (10.1%) | −120.9 | −118.8 | 0.40 |
| SMARCC1 SRX11379517 | Liposarcoma, Myxoid Adipocyte | 190 / 11891 (1.6%) | 7275 / 118910 (6.1%) | −120.7 | −118.6 | 0.26 |
| AR SRX1067066 | LHSAR Prostate | 532 / 11891 (4.5%) | 12640 / 118910 (10.6%) | −120.4 | −118.3 | 0.42 |
| Epitope tags SRX15939724 | RD Muscle | 200 / 11891 (1.7%) | 7440 / 118910 (6.3%) | −120.3 | −118.3 | 0.27 |
| ATF1 SRX11470450 | Mesenchymal stem cells Others | 483 / 11891 (4.1%) | 11921 / 118910 (10.0%) | −120.3 | −118.2 | 0.41 |
| FOXA1 SRX3923529 | ZR-75-1 Breast | 218 / 11891 (1.8%) | 7747 / 118910 (6.5%) | −120.2 | −118.1 | 0.28 |
| DNA-RNA hybrid SRX21658481 | U2OS Bone | 459 / 11891 (3.9%) | 1071 / 118910 (0.9%) | −120.1 | −118.0 | 4.29 |
| ESR1 SRX20282946 | MCF-7 Breast | 130 / 11891 (1.1%) | 6134 / 118910 (5.2%) | −119.7 | −117.6 | 0.21 |
| FOXA1 SRX1787652 | MCF-7 Breast | 135 / 11891 (1.1%) | 6230 / 118910 (5.2%) | −119.7 | −117.6 | 0.22 |
| TLE3 SRX4815192 | MCF-7 Breast | 214 / 11891 (1.8%) | 7657 / 118910 (6.4%) | −119.6 | −117.5 | 0.28 |
| NR3C1 SRX8520809 | SUM 159PT Breast | 201 / 11891 (1.7%) | 7430 / 118910 (6.2%) | −119.6 | −117.5 | 0.27 |
| WWTR1 SRX10119378 | MCF 10A Breast | 257 / 11891 (2.2%) | 8387 / 118910 (7.1%) | −119.5 | −117.5 | 0.31 |
| EP300 SRX027482 | hESC H9 Pluripotent stem cell | 202 / 11891 (1.7%) | 7444 / 118910 (6.3%) | −119.4 | −117.3 | 0.27 |
| FOXA2 SRX10475773 | Hep G2 Liver | 294 / 11891 (2.5%) | 8985 / 118910 (7.6%) | −119.4 | −117.3 | 0.33 |
| ZEB1 SRX13298925 | MCF-7 Breast | 136 / 11891 (1.1%) | 6231 / 118910 (5.2%) | −119.1 | −117.0 | 0.22 |
| CNOT3 SRX886405 | HCT 116 Digestive tract | 1328 / 11891 (11.2%) | 6378 / 118910 (5.4%) | −119.1 | −117.0 | 2.08 |
| NR1H3 SRX1538763 | HT-29 Digestive tract | 221 / 11891 (1.9%) | 7759 / 118910 (6.5%) | −119.0 | −117.0 | 0.28 |
| ESR1 SRX20282971 | MCF-7 Breast | 236 / 11891 (2.0%) | 8014 / 118910 (6.7%) | −119.0 | −116.9 | 0.29 |
| JUN SRX6582163 | BJ-5ta Epidermis | 299 / 11891 (2.5%) | 9042 / 118910 (7.6%) | −118.6 | −116.5 | 0.33 |
| GFP SRX6949256 | HeLa Uterus | 259 / 11891 (2.2%) | 8379 / 118910 (7.0%) | −118.4 | −116.3 | 0.31 |
| TFAP2C SRX018833 | MCF-7 Breast | 214 / 11891 (1.8%) | 7615 / 118910 (6.4%) | −118.3 | −116.2 | 0.28 |
| FOXA2 SRX6441755 | CFPAC-1 Pancreas | 173 / 11891 (1.5%) | 6893 / 118910 (5.8%) | −118.3 | −116.2 | 0.25 |
| SMAD3 SRX11483609 | Keratinocytes Epidermis | 347 / 11891 (2.9%) | 9786 / 118910 (8.2%) | −118.0 | −116.0 | 0.35 |
| RNF2 SRX18954719 | SCC-25 Others | 331 / 11891 (2.8%) | 9533 / 118910 (8.0%) | −118.0 | −116.0 | 0.35 |
| SREBF2 SRX5359048 | HCC70 Breast | 1180 / 11891 (9.9%) | 5379 / 118910 (4.5%) | −117.9 | −115.9 | 2.19 |
| FOS SRX3322637 | MCF-7 Breast | 113 / 11891 (1.0%) | 5747 / 118910 (4.8%) | −117.9 | −115.9 | 0.20 |
| AR SRX9109110 | MDA-MB-453 Breast | 474 / 11891 (4.0%) | 11698 / 118910 (9.8%) | −117.9 | −115.8 | 0.41 |
| AR SRX1067067 | LHSAR Prostate | 428 / 11891 (3.6%) | 11010 / 118910 (9.3%) | −117.7 | −115.6 | 0.39 |
| ESR1 SRX371474 | BT-474 Breast | 97 / 11891 (0.8%) | 5411 / 118910 (4.6%) | −117.6 | −115.5 | 0.18 |
| GATAD2A SRX2636507 | Hep G2 Liver | 260 / 11891 (2.2%) | 8363 / 118910 (7.0%) | −117.4 | −115.3 | 0.31 |
| NANOG SRX5286327 | ES cells Pluripotent stem cell | 163 / 11891 (1.4%) | 6679 / 118910 (5.6%) | −117.3 | −115.2 | 0.24 |
| ARID1A SRX5089391 | MCF-7 Breast | 121 / 11891 (1.0%) | 5885 / 118910 (4.9%) | −117.2 | −115.1 | 0.21 |
| JUNB SRX10119384 | MCF 10A Breast | 134 / 11891 (1.1%) | 6134 / 118910 (5.2%) | −117.1 | −115.1 | 0.22 |
| TEAD1 SRX14688734 | HUVEC Cardiovascular | 197 / 11891 (1.7%) | 7283 / 118910 (6.1%) | −117.1 | −115.1 | 0.27 |
| Epitope tags SRX5877914 | U2OS Bone | 1426 / 11891 (12.0%) | 24199 / 118910 (20.4%) | −117.1 | −115.1 | 0.59 |
| FOXA1 SRX028635 | MCF-7 Breast | 108 / 11891 (0.9%) | 5609 / 118910 (4.7%) | −116.6 | −114.6 | 0.19 |
| KDM1A SRX10637290 | MDA-MB-231 Breast | 320 / 11891 (2.7%) | 9304 / 118910 (7.8%) | −116.4 | −114.4 | 0.34 |
| AR SRX9469988 | LAPC-4 Prostate | 333 / 11891 (2.8%) | 9509 / 118910 (8.0%) | −116.4 | −114.4 | 0.35 |
| Epitope tags SRX11470534 | Mesenchymal stem cells Others | 466 / 11891 (3.9%) | 11528 / 118910 (9.7%) | −116.4 | −114.3 | 0.40 |
| FOXA1 SRX5323829 | T-47D Breast | 124 / 11891 (1.0%) | 5915 / 118910 (5.0%) | −116.3 | −114.2 | 0.21 |
| BRPF3 SRX796085 | RKO Digestive tract | 736 / 11891 (6.2%) | 2583 / 118910 (2.2%) | −116.2 | −114.2 | 2.85 |
| TFAP2C SRX128099 | MCF-7 Breast | 217 / 11891 (1.8%) | 7598 / 118910 (6.4%) | −116.1 | −114.1 | 0.29 |
| ESR1 SRX330067 | MCF-7 Breast | 220 / 11891 (1.9%) | 7648 / 118910 (6.4%) | −116.0 | −114.0 | 0.29 |
| NFYB SRX16608147 | HeLa Uterus | 200 / 11891 (1.7%) | 140 / 118910 (0.1%) | −115.9 | −113.9 | 14.29 |
| FOXA1 SRX8083099 | CAMA-1 Breast | 228 / 11891 (1.9%) | 7780 / 118910 (6.5%) | −115.9 | −113.9 | 0.29 |
| TRP47 SRX4548329 | THP-1 Blood | 1797 / 11891 (15.1%) | 9896 / 118910 (8.3%) | −115.8 | −113.8 | 1.82 |
| SP1 SRX190269 | A549 Lung | 361 / 11891 (3.0%) | 9924 / 118910 (8.3%) | −115.8 | −113.8 | 0.36 |
| HMG20A SRX2630163 | Hep G2 Liver | 124 / 11891 (1.0%) | 5902 / 118910 (5.0%) | −115.8 | −113.8 | 0.21 |
| ESR1 SRX3110725 | MCF-7 Breast | 218 / 11891 (1.8%) | 7600 / 118910 (6.4%) | −115.7 | −113.7 | 0.29 |
| CEBPA SRX2630241 | Hep G2 Liver | 303 / 11891 (2.5%) | 9000 / 118910 (7.6%) | −115.5 | −113.5 | 0.34 |
| NR3C1 SRX2609664 | HASM2 Lung | 349 / 11891 (2.9%) | 9724 / 118910 (8.2%) | −115.5 | −113.5 | 0.36 |
| NR3C1 SRX9298951 | Lung cancer cell line Lung | 141 / 11891 (1.2%) | 6219 / 118910 (5.2%) | −115.4 | −113.4 | 0.23 |
| FOSL2 SRX10640864 | SK-MEL-147 Epidermis | 331 / 11891 (2.8%) | 9444 / 118910 (7.9%) | −115.4 | −113.4 | 0.35 |
| BRD1 SRX286203 | RKO Digestive tract | 799 / 11891 (6.7%) | 2969 / 118910 (2.5%) | −115.4 | −113.4 | 2.69 |
| FOXA1 SRX15430999 | T-47D Breast | 276 / 11891 (2.3%) | 8560 / 118910 (7.2%) | −115.4 | −113.4 | 0.32 |
| SSRP1 SRX3436567 | HT-1080 Bone | 295 / 11891 (2.5%) | 427 / 118910 (0.4%) | −115.3 | −113.3 | 6.91 |
| PGR SRX1012655 | MCF-7 Breast | 148 / 11891 (1.2%) | 6339 / 118910 (5.3%) | −115.2 | −113.2 | 0.23 |
| SP1 SRX190358 | HCT 116 Digestive tract | 389 / 11891 (3.3%) | 10323 / 118910 (8.7%) | −115.0 | −113.0 | 0.38 |
| FOXA1 SRX100477 | Hep G2 Liver | 285 / 11891 (2.4%) | 8695 / 118910 (7.3%) | −115.0 | −113.0 | 0.33 |
| CDK9 SRX7366781 | MCF-7 Breast | 181 / 11891 (1.5%) | 100 / 118910 (0.1%) | −115.0 | −112.9 | 18.10 |
| EP300 SRX176885 | MCF-7 Breast | 119 / 11891 (1.0%) | 5768 / 118910 (4.9%) | −114.6 | −112.6 | 0.21 |
| SMARCA4 SRX8588623 | Pulmonary artery endothelial cells Cardiovascular | 354 / 11891 (3.0%) | 9772 / 118910 (8.2%) | −114.6 | −112.6 | 0.36 |
| FOSL1 SRX190212 | HCT 116 Digestive tract | 285 / 11891 (2.4%) | 8674 / 118910 (7.3%) | −114.5 | −112.5 | 0.33 |
| BMI1 SRX644729 | 293 Kidney | 184 / 11891 (1.5%) | 108 / 118910 (0.1%) | −114.3 | −112.3 | 17.04 |
| GFP SRX5417098 | HeLa Uterus | 287 / 11891 (2.4%) | 8701 / 118910 (7.3%) | −114.3 | −112.3 | 0.33 |
| ESR1 SRX371477 | MCF-7 Breast | 115 / 11891 (1.0%) | 5679 / 118910 (4.8%) | −114.3 | −112.3 | 0.20 |
| FOXA1 SRX1787655 | MCF-7 Breast | 117 / 11891 (1.0%) | 5718 / 118910 (4.8%) | −114.2 | −112.2 | 0.20 |
| TAL1 SRX393518 | Primary endothelial cells Cardiovascular | 354 / 11891 (3.0%) | 9755 / 118910 (8.2%) | −114.2 | −112.2 | 0.36 |
| ESR1 SRX20282953 | MCF-7 Breast | 197 / 11891 (1.7%) | 7189 / 118910 (6.0%) | −114.0 | −112.0 | 0.27 |
| FOS SRX070879 | HUVEC Cardiovascular | 259 / 11891 (2.2%) | 8235 / 118910 (6.9%) | −114.0 | −112.0 | 0.31 |
| EP300 SRX22550927 | CDS1 Bone | 387 / 11891 (3.3%) | 10256 / 118910 (8.6%) | −113.9 | −111.9 | 0.38 |
| CDK9 SRX7366783 | MCF-7 Breast | 183 / 11891 (1.5%) | 107 / 118910 (0.1%) | −113.9 | −111.9 | 17.10 |
| FOXA2 SRX5504126 | CFPAC-1 Pancreas | 142 / 11891 (1.2%) | 6182 / 118910 (5.2%) | −113.7 | −111.7 | 0.23 |
| ESR1 SRX330070 | MCF-7 Breast | 115 / 11891 (1.0%) | 5656 / 118910 (4.8%) | −113.5 | −111.5 | 0.20 |
| FOXA1 SRX3923517 | MCF-7 Breast | 170 / 11891 (1.4%) | 6687 / 118910 (5.6%) | −113.4 | −111.4 | 0.25 |
| FOSL2 SRX10475315 | Hep G2 Liver | 277 / 11891 (2.3%) | 8506 / 118910 (7.2%) | −113.3 | −111.3 | 0.33 |
| KAT7 SRX101303 | RKO Digestive tract | 903 / 11891 (7.6%) | 3649 / 118910 (3.1%) | −113.1 | −111.1 | 2.47 |
| ESR1 SRX2943589 | MCF-7 Breast | 118 / 11891 (1.0%) | 5705 / 118910 (4.8%) | −113.0 | −111.0 | 0.21 |
| FOXA2 SRX6441754 | CFPAC-1 Pancreas | 173 / 11891 (1.5%) | 6729 / 118910 (5.7%) | −112.9 | −110.9 | 0.26 |
| PROX1 SRX3230397 | Hep G2 Liver | 169 / 11891 (1.4%) | 6650 / 118910 (5.6%) | −112.7 | −110.7 | 0.25 |
| FOXL2 SRX6957477 | KGN Gonad | 257 / 11891 (2.2%) | 8156 / 118910 (6.9%) | −112.6 | −110.7 | 0.32 |
| ESR1 SRX330069 | MCF-7 Breast | 146 / 11891 (1.2%) | 6226 / 118910 (5.2%) | −112.6 | −110.7 | 0.23 |
| SMARCA4 SRX5075174 | Neural progenitor cells Neural | 420 / 11891 (3.5%) | 10702 / 118910 (9.0%) | −112.6 | −110.6 | 0.39 |
| NR3C1 SRX2609665 | HASM2 Lung | 280 / 11891 (2.4%) | 8532 / 118910 (7.2%) | −112.6 | −110.6 | 0.33 |
| ESR1 SRX1012632 | MCF-7 Breast | 110 / 11891 (0.9%) | 5531 / 118910 (4.7%) | −112.5 | −110.5 | 0.20 |
| FOSL2 SRX5054308 | Neural progenitor cells Neural | 177 / 11891 (1.5%) | 6783 / 118910 (5.7%) | −112.4 | −110.4 | 0.26 |
| ESR1 SRX20282938 | MCF-7 Breast | 195 / 11891 (1.6%) | 7100 / 118910 (6.0%) | −112.4 | −110.4 | 0.27 |
| JUN SRX2355072 | HAEC Cardiovascular | 328 / 11891 (2.8%) | 9284 / 118910 (7.8%) | −112.3 | −110.4 | 0.35 |
| SP1 SRX5457499 | Liver Liver | 445 / 11891 (3.7%) | 11065 / 118910 (9.3%) | −112.3 | −110.3 | 0.40 |
| FOXA1 SRX5323843 | MCF-7 Breast | 119 / 11891 (1.0%) | 5701 / 118910 (4.8%) | −112.3 | −110.3 | 0.21 |
| FOSL2 SRX190204 | A549 Lung | 242 / 11891 (2.0%) | 7897 / 118910 (6.6%) | −112.2 | −110.3 | 0.31 |
| NFIL3 SRX2630334 | Hep G2 Liver | 198 / 11891 (1.7%) | 7142 / 118910 (6.0%) | −112.1 | −110.1 | 0.28 |
| FOXA1 SRX3931033 | MCF-7 Breast | 152 / 11891 (1.3%) | 6319 / 118910 (5.3%) | −112.0 | −110.1 | 0.24 |
| NKX2-1 SRX366169 | NCI-H441 Lung | 298 / 11891 (2.5%) | 8798 / 118910 (7.4%) | −112.0 | −110.0 | 0.34 |
| EP300 SRX1012648 | MCF-7 Breast | 106 / 11891 (0.9%) | 5433 / 118910 (4.6%) | −111.9 | −109.9 | 0.20 |
| JUN SRX6582164 | BJ-5ta Epidermis | 312 / 11891 (2.6%) | 9011 / 118910 (7.6%) | −111.7 | −109.7 | 0.35 |
| ESR1 SRX8537723 | MCF-7 Breast | 195 / 11891 (1.6%) | 7076 / 118910 (6.0%) | −111.7 | −109.7 | 0.28 |
| ESR1 SRX5323871 | MCF-7 Breast | 275 / 11891 (2.3%) | 8412 / 118910 (7.1%) | −111.5 | −109.6 | 0.33 |
| YAP1 SRX10119388 | MDA-MB-231 Breast | 168 / 11891 (1.4%) | 6589 / 118910 (5.5%) | −111.4 | −109.5 | 0.25 |
| NR3C1 SRX8520802 | HCC1187 Breast | 186 / 11891 (1.6%) | 6909 / 118910 (5.8%) | −111.3 | −109.4 | 0.27 |
| FOXA1 SRX1961158 | T-47D Breast | 251 / 11891 (2.1%) | 8008 / 118910 (6.7%) | −111.2 | −109.3 | 0.31 |
| EP300 SRX100540 | SK-N-SH Neural | 375 / 11891 (3.2%) | 9972 / 118910 (8.4%) | −111.2 | −109.2 | 0.38 |
| ESR1 SRX1469949 | MCF-7 Breast | 133 / 11891 (1.1%) | 5934 / 118910 (5.0%) | −111.1 | −109.2 | 0.22 |
| FOXA1 SRX8083098 | CAMA-1 Breast | 202 / 11891 (1.7%) | 7181 / 118910 (6.0%) | −111.1 | −109.1 | 0.28 |
| Epitope tags SRX5877913 | U2OS Bone | 1426 / 11891 (12.0%) | 23902 / 118910 (20.1%) | −111.0 | −109.1 | 0.60 |
| GATA3 SRX6712581 | MCF-7 Breast | 207 / 11891 (1.7%) | 7264 / 118910 (6.1%) | −111.0 | −109.1 | 0.28 |
| ESR1 SRX10365532 | MCF-7 Breast | 129 / 11891 (1.1%) | 5856 / 118910 (4.9%) | −111.0 | −109.1 | 0.22 |
| FOXA1 SRX1961157 | T-47D Breast | 276 / 11891 (2.3%) | 8411 / 118910 (7.1%) | −111.0 | −109.0 | 0.33 |
| SOX5 SRX2636544 | Hep G2 Liver | 251 / 11891 (2.1%) | 8003 / 118910 (6.7%) | −110.9 | −109.0 | 0.31 |
| JUND SRX092301 | K-562 Blood | 328 / 11891 (2.8%) | 9229 / 118910 (7.8%) | −110.7 | −108.8 | 0.36 |
| OTX2 SRX702045 | hESC HUES64 Pluripotent stem cell | 184 / 11891 (1.5%) | 6853 / 118910 (5.8%) | −110.7 | −108.8 | 0.27 |
| YAP1 SRX1038945 | IMR-90 Lung | 183 / 11891 (1.5%) | 6830 / 118910 (5.7%) | −110.5 | −108.5 | 0.27 |
| CBX3 SRX190214 | HCT 116 Digestive tract | 448 / 11891 (3.8%) | 11033 / 118910 (9.3%) | −110.3 | −108.4 | 0.41 |
| ESR1 SRX3123829 | MCF-7 Breast | 135 / 11891 (1.1%) | 5952 / 118910 (5.0%) | −110.3 | −108.4 | 0.23 |
| ERG SRX026653 | CD34 Hematopoietic stem cells Blood | 1122 / 11891 (9.4%) | 5148 / 118910 (4.3%) | −110.3 | −108.3 | 2.18 |
| FOXA1 SRX1787651 | MCF-7 Breast | 136 / 11891 (1.1%) | 5967 / 118910 (5.0%) | −110.3 | −108.3 | 0.23 |
| GATA2 SRX3503584 | Endometrial stromal cells Uterus | 277 / 11891 (2.3%) | 8403 / 118910 (7.1%) | −110.3 | −108.3 | 0.33 |
| EP300 SRX2671792 | Cardiac progenitor cells Cardiovascular | 181 / 11891 (1.5%) | 6783 / 118910 (5.7%) | −110.1 | −108.2 | 0.27 |
| AR SRX9109113 | MDA-MB-453 Breast | 499 / 11891 (4.2%) | 11768 / 118910 (9.9%) | −110.1 | −108.2 | 0.42 |
| SOX2 SRX2731713 | Lung cancer cell line Lung | 175 / 11891 (1.5%) | 100 / 118910 (0.1%) | −109.8 | −107.9 | 17.50 |
| EP300 SRX1012644 | MCF-7 Breast | 101 / 11891 (0.8%) | 5271 / 118910 (4.4%) | −109.8 | −107.9 | 0.19 |
| FOXA1 SRX3931056 | MCF-7 Breast | 142 / 11891 (1.2%) | 6063 / 118910 (5.1%) | −109.8 | −107.9 | 0.23 |
| RNF2 SRX18954704 | FaDu Others | 626 / 11891 (5.3%) | 13550 / 118910 (11.4%) | −109.7 | −107.8 | 0.46 |
| FOXA1 SRX1447316 | MCF-7 Breast | 95 / 11891 (0.8%) | 5144 / 118910 (4.3%) | −109.6 | −107.7 | 0.18 |
| ESR1 SRX4451213 | MCF-7 Breast | 257 / 11891 (2.2%) | 8053 / 118910 (6.8%) | −109.6 | −107.6 | 0.32 |
| ESR1 SRX5323873 | MCF-7 Breast | 316 / 11891 (2.7%) | 8998 / 118910 (7.6%) | −109.5 | −107.6 | 0.35 |
| FOXA1 SRX11222438 | MCF-7 Breast | 127 / 11891 (1.1%) | 5770 / 118910 (4.9%) | −109.4 | −107.4 | 0.22 |
| ESR1 SRX1161185 | ZR-75-1 Breast | 116 / 11891 (1.0%) | 5556 / 118910 (4.7%) | −109.4 | −107.4 | 0.21 |
| MYC SRX150570 | MCF 10A Breast | 158 / 11891 (1.3%) | 6344 / 118910 (5.3%) | −109.2 | −107.3 | 0.25 |
| ESR1 SRX20282959 | MCF-7 Breast | 91 / 11891 (0.8%) | 5053 / 118910 (4.2%) | −109.2 | −107.3 | 0.18 |
| ZEB1 SRX13298923 | MCF-7 Breast | 94 / 11891 (0.8%) | 5113 / 118910 (4.3%) | −109.1 | −107.2 | 0.18 |
| FOXA1 SRX3923516 | MCF-7 Breast | 182 / 11891 (1.5%) | 6765 / 118910 (5.7%) | −109.1 | −107.1 | 0.27 |
| Epitope tags SRX15939725 | RD Muscle | 192 / 11891 (1.6%) | 6942 / 118910 (5.8%) | −109.0 | −107.1 | 0.28 |
| FOXA1 SRX15430987 | MDA-MB-453 Breast | 382 / 11891 (3.2%) | 10000 / 118910 (8.4%) | −109.0 | −107.1 | 0.38 |
| FOXA1 SRX13814018 | 5637 Others | 154 / 11891 (1.3%) | 6261 / 118910 (5.3%) | −108.9 | −107.0 | 0.25 |
| RELA SRX7055007 | HAEC Cardiovascular | 477 / 11891 (4.0%) | 11402 / 118910 (9.6%) | −108.9 | −107.0 | 0.42 |
| SMARCA4 SRX5716469 | Neural progenitor cells Neural | 164 / 11891 (1.4%) | 6437 / 118910 (5.4%) | −108.9 | −107.0 | 0.25 |
| FOXA1 SRX190181 | A549 Lung | 172 / 11891 (1.4%) | 6583 / 118910 (5.5%) | −108.8 | −106.9 | 0.26 |
| TEAD4 SRX10640862 | SK-MEL-147 Epidermis | 402 / 11891 (3.4%) | 10289 / 118910 (8.7%) | −108.7 | −106.7 | 0.39 |
| TRIM25 SRX1660873 | Breast cancer cells Breast | 1319 / 11891 (11.1%) | 6561 / 118910 (5.5%) | −108.6 | −106.7 | 2.01 |
| FOXA1 SRX3923528 | ZR-75-1 Breast | 167 / 11891 (1.4%) | 6483 / 118910 (5.5%) | −108.5 | −106.6 | 0.26 |
| MITF SRX7368255 | Hermes 3C Epidermis | 757 / 11891 (6.4%) | 15284 / 118910 (12.9%) | −108.5 | −106.6 | 0.50 |
| NR3C1 SRX2609662 | HASM2 Lung | 315 / 11891 (2.6%) | 8933 / 118910 (7.5%) | −108.1 | −106.2 | 0.35 |
| FOSL2 SRX10475316 | Hep G2 Liver | 345 / 11891 (2.9%) | 9400 / 118910 (7.9%) | −108.1 | −106.2 | 0.37 |
| ESR1 SRX5323878 | MCF-7 Breast | 256 / 11891 (2.2%) | 7986 / 118910 (6.7%) | −108.0 | −106.1 | 0.32 |
| FOXA3 SRX2630190 | Hep G2 Liver | 211 / 11891 (1.8%) | 7235 / 118910 (6.1%) | −108.0 | −106.1 | 0.29 |
| FOXA1 SRX3923532 | ZR-75-1 Breast | 166 / 11891 (1.4%) | 6447 / 118910 (5.4%) | −108.0 | −106.1 | 0.26 |
| FOXA2 SRX2368889 | Ker-CT Epidermis | 207 / 11891 (1.7%) | 7167 / 118910 (6.0%) | −108.0 | −106.1 | 0.29 |
| BRPF3 SRX796084 | RKO Digestive tract | 1003 / 11891 (8.4%) | 4396 / 118910 (3.7%) | −108.0 | −106.1 | 2.28 |
| ELF3 SRX825394 | CFPAC-1 Pancreas | 424 / 11891 (3.6%) | 10589 / 118910 (8.9%) | −107.9 | −106.0 | 0.40 |
| ARID1A SRX5089385 | MCF-7 Breast | 189 / 11891 (1.6%) | 6851 / 118910 (5.8%) | −107.9 | −106.0 | 0.28 |
| FOXA1 SRX9550865 | Prostate cancer Prostate | 510 / 11891 (4.3%) | 11840 / 118910 (10.0%) | −107.8 | −105.9 | 0.43 |
| FOXA1 SRX5124036 | 22Rv1 Prostate | 271 / 11891 (2.3%) | 8220 / 118910 (6.9%) | −107.7 | −105.8 | 0.33 |
| CEBPB SRX11379527 | Liposarcoma, Myxoid Adipocyte | 473 / 11891 (4.0%) | 11295 / 118910 (9.5%) | −107.7 | −105.8 | 0.42 |
| RXRB SRX2636027 | Hep G2 Liver | 276 / 11891 (2.3%) | 8299 / 118910 (7.0%) | −107.6 | −105.7 | 0.33 |
| RNF2 SRX18954706 | SCC-25 Others | 320 / 11891 (2.7%) | 8997 / 118910 (7.6%) | −107.6 | −105.7 | 0.36 |
| Epitope tags SRX20741907 | Hep G2 Liver | 346 / 11891 (2.9%) | 9399 / 118910 (7.9%) | −107.6 | −105.7 | 0.37 |
| SS18 SRX10640841 | SK-MEL-147 Epidermis | 376 / 11891 (3.2%) | 9854 / 118910 (8.3%) | −107.5 | −105.6 | 0.38 |
| ZEB1 SRX13298924 | MCF-7 Breast | 115 / 11891 (1.0%) | 5483 / 118910 (4.6%) | −107.5 | −105.6 | 0.21 |
| Epitope tags SRX20741925 | Hep G2 Liver | 458 / 11891 (3.9%) | 11067 / 118910 (9.3%) | −107.4 | −105.5 | 0.41 |
| FOXA2 SRX11650944 | hESC derived pancreatic cells Pluripotent stem cell | 220 / 11891 (1.9%) | 7359 / 118910 (6.2%) | −107.2 | −105.3 | 0.30 |
| SMARCA4 SRX8566546 | 786-O Kidney | 915 / 11891 (7.7%) | 17310 / 118910 (14.6%) | −107.1 | −105.3 | 0.53 |
| ZNF219 SRX3230413 | Hep G2 Liver | 457 / 11891 (3.8%) | 11042 / 118910 (9.3%) | −107.1 | −105.2 | 0.41 |
| KMT2C SRX1787675 | MCF-7 Breast | 221 / 11891 (1.9%) | 7369 / 118910 (6.2%) | −107.0 | −105.1 | 0.30 |
| SMARCA4 SRX5075168 | Neural progenitor cells Neural | 374 / 11891 (3.1%) | 9792 / 118910 (8.2%) | −106.7 | −104.8 | 0.38 |
| ESR1 SRX1012633 | MCF-7 Breast | 124 / 11891 (1.0%) | 5631 / 118910 (4.7%) | −106.6 | −104.7 | 0.22 |
| PRDM10 SRX3230396 | Hep G2 Liver | 475 / 11891 (4.0%) | 11283 / 118910 (9.5%) | −106.6 | −104.7 | 0.42 |
| ESR1 SRX1012629 | MCF-7 Breast | 156 / 11891 (1.3%) | 6218 / 118910 (5.2%) | −106.4 | −104.5 | 0.25 |
| EP300 SRX717860 | HeLa Uterus | 157 / 11891 (1.3%) | 6234 / 118910 (5.2%) | −106.3 | −104.5 | 0.25 |
| SOX6 SRX10475370 | Hep G2 Liver | 467 / 11891 (3.9%) | 11154 / 118910 (9.4%) | −106.2 | −104.4 | 0.42 |
| HOXC5 SRX2731653 | PC-3 Prostate | 201 / 11891 (1.7%) | 7006 / 118910 (5.9%) | −106.2 | −104.3 | 0.29 |
| BMI1 SRX7196715 | SU-DIPG-IV Neural | 1229 / 11891 (10.3%) | 5980 / 118910 (5.0%) | −106.2 | −104.3 | 2.06 |
| BRD4 SRX3031983 | MV-4-11 Blood | 356 / 11891 (3.0%) | 9498 / 118910 (8.0%) | −106.1 | −104.2 | 0.37 |
| FOXA1 SRX3931032 | MCF-7 Breast | 144 / 11891 (1.2%) | 5989 / 118910 (5.0%) | −106.0 | −104.1 | 0.24 |
| SMARCA4 SRX15419260 | 786-O Kidney | 918 / 11891 (7.7%) | 17294 / 118910 (14.5%) | −106.0 | −104.1 | 0.53 |
| ESR1 SRX10365533 | MCF-7 Breast | 117 / 11891 (1.0%) | 5473 / 118910 (4.6%) | −105.9 | −104.0 | 0.21 |
| FOXA1 SRX3923518 | MCF-7 Breast | 173 / 11891 (1.5%) | 6507 / 118910 (5.5%) | −105.9 | −104.0 | 0.27 |
| ARID1A SRX5089382 | MCF-7 Breast | 182 / 11891 (1.5%) | 6660 / 118910 (5.6%) | −105.7 | −103.8 | 0.27 |
| NR3C1 SRX10977357 | A549 Lung | 149 / 11891 (1.3%) | 6068 / 118910 (5.1%) | −105.7 | −103.8 | 0.25 |
| FOXA1 SRX5323830 | T-47D Breast | 149 / 11891 (1.3%) | 6069 / 118910 (5.1%) | −105.7 | −103.8 | 0.25 |
| TEAD4 SRX10640861 | SK-MEL-147 Epidermis | 285 / 11891 (2.4%) | 8373 / 118910 (7.0%) | −105.7 | −103.8 | 0.34 |
| NR3C1 SRX10976921 | A549 Lung | 175 / 11891 (1.5%) | 6534 / 118910 (5.5%) | −105.6 | −103.7 | 0.27 |
| FOXA1 SRX9550926 | Prostate cancer Prostate | 316 / 11891 (2.7%) | 8862 / 118910 (7.5%) | −105.6 | −103.7 | 0.36 |
| ESR1 SRX1469951 | MCF-7 Breast | 125 / 11891 (1.1%) | 5618 / 118910 (4.7%) | −105.6 | −103.7 | 0.22 |
| JUND SRX150648 | K-562 Blood | 343 / 11891 (2.9%) | 9275 / 118910 (7.8%) | −105.5 | −103.6 | 0.37 |
| ESR1 SRX330068 | MCF-7 Breast | 112 / 11891 (0.9%) | 5365 / 118910 (4.5%) | −105.5 | −103.6 | 0.21 |
| EP300 SRX717859 | HeLa Uterus | 127 / 11891 (1.1%) | 5649 / 118910 (4.8%) | −105.4 | −103.6 | 0.22 |
| SMARCA4 SRX8588626 | Pulmonary artery endothelial cells Cardiovascular | 355 / 11891 (3.0%) | 9451 / 118910 (7.9%) | −105.3 | −103.4 | 0.38 |
| STAT3 SRX4192888 | MCF 10A Breast | 117 / 11891 (1.0%) | 5453 / 118910 (4.6%) | −105.1 | −103.2 | 0.21 |
| FOXA2 SRX11650948 | hESC derived pancreatic cells Pluripotent stem cell | 224 / 11891 (1.9%) | 7358 / 118910 (6.2%) | −105.1 | −103.2 | 0.30 |
| CEBPB SRX190345 | MCF-7 Breast | 199 / 11891 (1.7%) | 6933 / 118910 (5.8%) | −105.0 | −103.1 | 0.29 |
| RUNX1 SRX2014504 | Jurkat Blood | 1641 / 11891 (13.8%) | 9034 / 118910 (7.6%) | −105.0 | −103.1 | 1.82 |
| NR3C1 SRX10977372 | A549 Lung | 139 / 11891 (1.2%) | 5857 / 118910 (4.9%) | −104.7 | −102.9 | 0.24 |
| VGLL1 SRX18013277 | FULVR Breast | 103 / 11891 (0.9%) | 5167 / 118910 (4.3%) | −104.7 | −102.9 | 0.20 |
| FOXA1 SRX6878603 | LNCAP Prostate | 297 / 11891 (2.5%) | 8530 / 118910 (7.2%) | −104.7 | −102.8 | 0.35 |
| EP300 SRX1012643 | MCF-7 Breast | 83 / 11891 (0.7%) | 4758 / 118910 (4.0%) | −104.6 | −102.8 | 0.17 |
| SMARCA4 SRX5716470 | Neural progenitor cells Neural | 222 / 11891 (1.9%) | 7294 / 118910 (6.1%) | −104.1 | −102.3 | 0.30 |
| JUNB SRX10119385 | MCF 10A Breast | 108 / 11891 (0.9%) | 5246 / 118910 (4.4%) | −104.0 | −102.2 | 0.21 |
| FOXA1 SRX17794420 | 22Rv1 Prostate | 168 / 11891 (1.4%) | 6358 / 118910 (5.3%) | −103.9 | −102.1 | 0.26 |
| IKZF1 SRX2424551 | GM12878 Blood | 493 / 11891 (4.1%) | 11441 / 118910 (9.6%) | −103.8 | −102.0 | 0.43 |
| FOS SRX150664 | HUVEC Cardiovascular | 350 / 11891 (2.9%) | 9318 / 118910 (7.8%) | −103.7 | −101.8 | 0.38 |
| YAP1 SRX10119387 | MDA-MB-231 Breast | 194 / 11891 (1.6%) | 6797 / 118910 (5.7%) | −103.5 | −101.6 | 0.29 |
| FOXA1 SRX190282 | A549 Lung | 175 / 11891 (1.5%) | 6466 / 118910 (5.4%) | −103.4 | −101.6 | 0.27 |
| JUN SRX2355073 | HAEC Cardiovascular | 332 / 11891 (2.8%) | 9030 / 118910 (7.6%) | −103.4 | −101.6 | 0.37 |
| MEAF6 SRX10606584 | GIST-T1 Digestive tract | 1060 / 11891 (8.9%) | 4877 / 118910 (4.1%) | −103.3 | −101.4 | 2.17 |
| FOXA1 SRX3923530 | ZR-75-1 Breast | 171 / 11891 (1.4%) | 6385 / 118910 (5.4%) | −103.2 | −101.4 | 0.27 |
| NR3C1 SRX17639413 | A549 Lung | 173 / 11891 (1.5%) | 6419 / 118910 (5.4%) | −103.1 | −101.2 | 0.27 |
| RNF2 SRX18954702 | FaDu Others | 612 / 11891 (5.1%) | 13080 / 118910 (11.0%) | −103.1 | −101.2 | 0.47 |
| NR3C1 SRX10977373 | A549 Lung | 134 / 11891 (1.1%) | 5710 / 118910 (4.8%) | −103.0 | −101.2 | 0.23 |
| EP300 SRX10976215 | A549 Lung | 240 / 11891 (2.0%) | 7540 / 118910 (6.3%) | −102.6 | −100.8 | 0.32 |
| ARID1A SRX5679787 | 12Z Others | 96 / 11891 (0.8%) | 4964 / 118910 (4.2%) | −102.6 | −100.8 | 0.19 |
| WWTR1 SRX10119368 | MCF 10A Breast | 186 / 11891 (1.6%) | 6623 / 118910 (5.6%) | −102.4 | −100.5 | 0.28 |
| CEBPB SRX2194250 | SUM 159PT Breast | 330 / 11891 (2.8%) | 8960 / 118910 (7.5%) | −102.3 | −100.5 | 0.37 |
| FOXA1 SRX3923531 | ZR-75-1 Breast | 148 / 11891 (1.2%) | 5947 / 118910 (5.0%) | −102.3 | −100.5 | 0.25 |
| ASPSCR1 SRX17321275 | ASPS1 Lung | 455 / 11891 (3.8%) | 10831 / 118910 (9.1%) | −102.3 | −100.5 | 0.42 |
| FOXA1 SRX3923515 | MCF-7 Breast | 147 / 11891 (1.2%) | 5927 / 118910 (5.0%) | −102.2 | −100.4 | 0.25 |
| JUN SRX9350646 | Melanoma cell line Epidermis | 359 / 11891 (3.0%) | 9403 / 118910 (7.9%) | −102.2 | −100.4 | 0.38 |
| ARID1A SRX5089388 | MCF-7 Breast | 130 / 11891 (1.1%) | 5608 / 118910 (4.7%) | −102.1 | −100.3 | 0.23 |
| RELA SRX7054617 | HAEC Cardiovascular | 329 / 11891 (2.8%) | 8938 / 118910 (7.5%) | −102.1 | −100.2 | 0.37 |
| NR3C1 SRX2609666 | HASM2 Lung | 261 / 11891 (2.2%) | 7865 / 118910 (6.6%) | −102.0 | −100.2 | 0.33 |
| MITF SRX7368256 | Hermes 3C Epidermis | 533 / 11891 (4.5%) | 11929 / 118910 (10.0%) | −101.8 | −100.0 | 0.45 |
| SMARCA4 SRX5982340 | A549 Lung | 94 / 11891 (0.8%) | 4893 / 118910 (4.1%) | −101.6 | −99.8 | 0.19 |
| ESR1 SRX1531796 | MCF-7 Breast | 137 / 11891 (1.2%) | 5723 / 118910 (4.8%) | −101.6 | −99.8 | 0.24 |
| FOXA1 SRX1161205 | T-47D Breast | 138 / 11891 (1.2%) | 5739 / 118910 (4.8%) | −101.5 | −99.7 | 0.24 |
| Epitope tags SRX8080559 | Mammary gland adenocarcinoma Breast | 104 / 11891 (0.9%) | 5093 / 118910 (4.3%) | −101.5 | −99.7 | 0.20 |
| NR3C1 SRX18884271 | A549 Lung | 133 / 11891 (1.1%) | 5636 / 118910 (4.7%) | −101.2 | −99.3 | 0.24 |
| FOXA1 SRX6860635 | T-47D Breast | 205 / 11891 (1.7%) | 6905 / 118910 (5.8%) | −101.1 | −99.3 | 0.30 |
| CREB1 SRX5661984 | Kidney Cortex Kidney | 525 / 11891 (4.4%) | 11783 / 118910 (9.9%) | −101.1 | −99.3 | 0.45 |
| HDAC2 SRX190281 | MCF-7 Breast | 234 / 11891 (2.0%) | 7391 / 118910 (6.2%) | −101.1 | −99.2 | 0.32 |
| ESR1 SRX10365558 | MCF-7 Breast | 180 / 11891 (1.5%) | 6477 / 118910 (5.4%) | −101.0 | −99.2 | 0.28 |
| TEAD1 SRX1011298 | HuCCT1 Liver | 103 / 11891 (0.9%) | 5059 / 118910 (4.3%) | −101.0 | −99.2 | 0.20 |
| MITF SRX1555436 | 501A Epidermis | 1307 / 11891 (11.0%) | 6666 / 118910 (5.6%) | −101.0 | −99.2 | 1.96 |
Showing first 500 of 18199 rows.